Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Trevena Inc.
The year began with an unusually low number of CRLs, but a recent burst of non-approval actions suggests a COVID-19 effect.
Sixteen applications are in line for US FDA decisions in August. Ten are novel agents.
With goal dates for almost 40 novel drugs and biologics coming up in the second half of 2020 after a record number of first half approvals, even the pandemic looks unlikely to prevent another solid year for innovative drugs at US FDA.
The latest drug development news and highlights from our US FDA Performance Tracker.
- Drug Discovery Tools
- Large Molecule